<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals Ltd has informed BSE that it does not meet the criteria to be classified as a 'Large Corporate' under SEBI's circular dated November 2018, as on March 31, 2025. The company has confirmed this by submitting Annexure A, stating its outstanding borrowings fall below the threshold required for the Large Corporate tag. The filing is signed by the Company Secretary and CFO. This is a routine annual compliance disclosure rather than a material business event.
No material impact on shareholders or the stock price. This is a standard regulatory filing confirming the company is below SEBI's large borrowing threshold, meaning mandatory debt-market borrowing norms do not apply to it for the current financial year.